Investors were encouraged by news that Gilead’s remdesivir drug was found to significantly improve clinical recovery and reduced the risk of death in COVID-19 patients. Shares in Gilead rose 2.2%. Shares in Netflix rose 8.1% on a broker upgrade.
Post Views: 422